List of Excipients in API hydrochlorothiazide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing hydrochlorothiazide
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Actavis Pharma Inc | HYDROCHLOROTHIAZIDE | hydrochlorothiazide | 0591-0347 | D&C RED NO. 28 | |
| Actavis Pharma Inc | HYDROCHLOROTHIAZIDE | hydrochlorothiazide | 0591-0347 | D&C YELLOW NO. 10 | |
| Actavis Pharma Inc | HYDROCHLOROTHIAZIDE | hydrochlorothiazide | 0591-0347 | FD&C BLUE NO. 1 | |
| Actavis Pharma Inc | HYDROCHLOROTHIAZIDE | hydrochlorothiazide | 0591-0347 | FD&C BLUE NO. 2 | |
| Actavis Pharma Inc | HYDROCHLOROTHIAZIDE | hydrochlorothiazide | 0591-0347 | FD&C RED NO. 40 | |
| Actavis Pharma Inc | HYDROCHLOROTHIAZIDE | hydrochlorothiazide | 0591-0347 | FERROSOFERRIC OXIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing hydrochlorothiazide
Detailed excipient profiles for hydrochlorothiazide
Excipient focus: ALCOHOL
hydrochlorothiazide drug variants containing ALCOHOL
hydrochlorothiazide drug variants not containing ALCOHOL
Excipient focus: ALUMINUM OXIDE
hydrochlorothiazide drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | hydrochlorothiazide | 0527-1413 |
| Lannett Company Inc | hydrochlorothiazide | 0527-1635 |
| Physicians Total Care Inc | hydrochlorothiazide | 54868-0792 |
| MedVantx Inc | hydrochlorothiazide | 66116-234 |
| Legacy Pharmaceutical Packaging LLC | hydrochlorothiazide | 68645-510 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide drug variants not containing ALUMINUM OXIDE
Excipient focus: AMMONIA
hydrochlorothiazide drug variants containing AMMONIA
hydrochlorothiazide drug variants not containing AMMONIA
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
hydrochlorothiazide drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
hydrochlorothiazide drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Excipient focus: ANHYDROUS LACTOSE
hydrochlorothiazide drug variants containing ANHYDROUS LACTOSE
hydrochlorothiazide drug variants not containing ANHYDROUS LACTOSE
Excipient focus: BENZYL ALCOHOL
hydrochlorothiazide drug variants containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide drug variants not containing BENZYL ALCOHOL
Excipient focus: BUTYL ALCOHOL
hydrochlorothiazide drug variants containing BUTYL ALCOHOL
hydrochlorothiazide drug variants not containing BUTYL ALCOHOL
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
hydrochlorothiazide drug variants containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| MedVantx Inc | hydrochlorothiazide | 66116-234 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide drug variants not containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
hydrochlorothiazide drug variants containing CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
hydrochlorothiazide drug variants not containing CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
Excipient focus: CALCIUM STEARATE
hydrochlorothiazide drug variants containing CALCIUM STEARATE
hydrochlorothiazide drug variants not containing CALCIUM STEARATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
hydrochlorothiazide drug variants containing CELLULOSE, MICROCRYSTALLINE
hydrochlorothiazide drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CETYLPYRIDINIUM CHLORIDE
hydrochlorothiazide drug variants containing CETYLPYRIDINIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide drug variants not containing CETYLPYRIDINIUM CHLORIDE
Excipient focus: COLLOIDAL SILICON DIOXIDE
hydrochlorothiazide drug variants containing COLLOIDAL SILICON DIOXIDE
hydrochlorothiazide drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: CROSCARMELLOSE SODIUM
hydrochlorothiazide drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Liberty Pharmaceuticals Inc | hydrochlorothiazide | 0440-1595 |
| State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: D&C RED NO. 28
hydrochlorothiazide drug variants containing D&C RED NO. 28
hydrochlorothiazide drug variants not containing D&C RED NO. 28
Excipient focus: D&C RED NO. 33
hydrochlorothiazide drug variants containing D&C RED NO. 33
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide drug variants not containing D&C RED NO. 33
Excipient focus: D&C YELLOW NO. 10
hydrochlorothiazide drug variants containing D&C YELLOW NO. 10
hydrochlorothiazide drug variants not containing D&C YELLOW NO. 10
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
hydrochlorothiazide drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
hydrochlorothiazide drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
hydrochlorothiazide drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
hydrochlorothiazide drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Excipient focus: DOCUSATE SODIUM
hydrochlorothiazide drug variants containing DOCUSATE SODIUM
hydrochlorothiazide drug variants not containing DOCUSATE SODIUM
Excipient focus: FD&C BLUE NO. 1
hydrochlorothiazide drug variants containing FD&C BLUE NO. 1
hydrochlorothiazide drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
hydrochlorothiazide drug variants containing FD&C BLUE NO. 2
hydrochlorothiazide drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C RED NO. 3
hydrochlorothiazide drug variants containing FD&C RED NO. 3
hydrochlorothiazide drug variants not containing FD&C RED NO. 3
Excipient focus: FD&C RED NO. 40
hydrochlorothiazide drug variants containing FD&C RED NO. 40
hydrochlorothiazide drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
hydrochlorothiazide drug variants containing FD&C YELLOW NO. 6
hydrochlorothiazide drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
hydrochlorothiazide drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Liberty Pharmaceuticals Inc | hydrochlorothiazide | 0440-1595 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
hydrochlorothiazide drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Liberty Pharmaceuticals Inc | hydrochlorothiazide | 0440-1595 |
| State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
hydrochlorothiazide drug variants containing FERROSOFERRIC OXIDE
hydrochlorothiazide drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
hydrochlorothiazide drug variants containing GELATIN
hydrochlorothiazide drug variants not containing GELATIN
Excipient focus: GLYCINE
hydrochlorothiazide drug variants containing GLYCINE
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide drug variants not containing GLYCINE
Excipient focus: ISOPROPYL ALCOHOL
hydrochlorothiazide drug variants containing ISOPROPYL ALCOHOL
hydrochlorothiazide drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LACTOSE
hydrochlorothiazide drug variants containing LACTOSE
hydrochlorothiazide drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
hydrochlorothiazide drug variants containing LACTOSE MONOHYDRATE
hydrochlorothiazide drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
hydrochlorothiazide drug variants containing MAGNESIUM STEARATE
hydrochlorothiazide drug variants not containing MAGNESIUM STEARATE
Excipient focus: METHYL ALCOHOL
hydrochlorothiazide drug variants containing METHYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | hydrochlorothiazide | 0527-1635 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide drug variants not containing METHYL ALCOHOL
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
hydrochlorothiazide drug variants containing MICROCRYSTALLINE CELLULOSE 101
hydrochlorothiazide drug variants not containing MICROCRYSTALLINE CELLULOSE 101
Excipient focus: POLYETHYLENE GLYCOL
hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYSORBATE 80
hydrochlorothiazide drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide drug variants not containing POLYSORBATE 80
Excipient focus: POTASSIUM HYDROXIDE
hydrochlorothiazide drug variants containing POTASSIUM HYDROXIDE
hydrochlorothiazide drug variants not containing POTASSIUM HYDROXIDE
Excipient focus: POVIDONE
hydrochlorothiazide drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| GlaxoSmithKline LLC | hydrochlorothiazide and triamterene | 0007-3650 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide drug variants not containing POVIDONE
Excipient focus: PROPYLENE GLYCOL
hydrochlorothiazide drug variants containing PROPYLENE GLYCOL
hydrochlorothiazide drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
hydrochlorothiazide drug variants containing SHELLAC
hydrochlorothiazide drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
hydrochlorothiazide drug variants containing SILICON DIOXIDE
hydrochlorothiazide drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM BENZOATE
hydrochlorothiazide drug variants containing SODIUM BENZOATE
hydrochlorothiazide drug variants not containing SODIUM BENZOATE
Excipient focus: SODIUM BICARBONATE
hydrochlorothiazide drug variants containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | hydrochlorothiazide and triamterene | 53808-0802 |
| >Company | >Ingredient | >NDC |
hydrochlorothiazide drug variants not containing SODIUM BICARBONATE
Excipient focus: SODIUM LAURYL SULFATE
hydrochlorothiazide drug variants containing SODIUM LAURYL SULFATE
hydrochlorothiazide drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A CORN
hydrochlorothiazide drug variants containing SODIUM STARCH GLYCOLATE TYPE A CORN
hydrochlorothiazide drug variants not containing SODIUM STARCH GLYCOLATE TYPE A CORN
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
hydrochlorothiazide drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
hydrochlorothiazide drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
hydrochlorothiazide drug variants containing STARCH, CORN
hydrochlorothiazide drug variants not containing STARCH, CORN
Excipient focus: STARCH, PREGELATINIZED CORN
hydrochlorothiazide drug variants containing STARCH, PREGELATINIZED CORN
hydrochlorothiazide drug variants not containing STARCH, PREGELATINIZED CORN
Excipient focus: STEARIC ACID
hydrochlorothiazide drug variants containing STEARIC ACID
hydrochlorothiazide drug variants not containing STEARIC ACID
Excipient focus: TITANIUM DIOXIDE
hydrochlorothiazide drug variants containing TITANIUM DIOXIDE
hydrochlorothiazide drug variants not containing TITANIUM DIOXIDE
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
